US2005170381A1PendingUtilityA1

Oncoprotein protein kinase

54
Assignee: UNIV MASSACHUSETTS MEDICALPriority: Jul 19, 1993Filed: Oct 21, 2004Published: Aug 4, 2005
Est. expiryJul 19, 2013(expired)· nominal 20-yr term from priority
G01N 2333/9121C12N 9/12G01N 2333/91215A61K 38/00C07K 16/40G01N 33/53C12Q 1/485
54
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An isolated polypeptide (JNK) characterized by having a molecular weight of 46 kD as determined by reducing SDS-PAGE, having serine and Threonine kinase activity, phosphorylating the c-Jun N-terminal activation domain and polynucleotide sequences and method of deterction of JNK are provided herein. JNK phosphorylates c-Jun N-terminal activation domain which affects gene expression from AP-1 sites.

Claims

exact text as granted — not AI-modified
1 . A method for identifying a composition which affects a kinase characterized as having serine and threonine kinase activity and phosphorylating a c-Jun N-terminal activation domain, comprising: 
 a) incubating components comprising the composition and the kinase or polynucleotide encoding the kinase, wherein the incubating is carried out under conditions sufficient to allow the components to interact; and    b) measuring the effect of the composition on the kinase or polynucleotide encoding the kinase.    
     
     
         2 - 9 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.